{"id":36442,"date":"2025-07-31T16:54:30","date_gmt":"2025-07-31T13:54:30","guid":{"rendered":"https:\/\/massivebio.com\/?p=36442"},"modified":"2025-07-31T17:04:12","modified_gmt":"2025-07-31T14:04:12","slug":"massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant","status":"publish","type":"post","link":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/","title":{"rendered":"MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant"},"content":{"rendered":"

Boca Raton, FL \u2013 July 31, 2025 \u2014 In direct support of the White House and CMS\u2019s bold initiative to \u201c<\/strong>Make Health Tech Great Again,<\/strong><\/a>\u201d<\/strong> Massive Bio<\/a>, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem<\/strong> and reaffirmed its mission to modernize clinical trial access through secure, AI-powered patient-facing technology. With its Patient Connect<\/strong> <\/a>app and intelligent assistant DrArturoAI<\/strong> <\/a>already live and serving patients, Massive Bio stands as one of the first organizations actively delivering on CMS\u2019s interoperability framework at scale.<\/p>\n

\u201cWe\u2019re not waiting for transformation, we\u2019ve already launched it,\u201d said Selin Kurnaz<\/strong><\/a>, PhD, CEO and Co-Founder of Massive Bio<\/strong>. \u201cPatient Connect represents a new era of patient empowerment: secure identity, real-time data access, AI-guided decision-making. We\u2019ve operationalized CMS\u2019s vision, and we\u2019re proud to serve the public with technology that puts them in control of their care journey.\u201d<\/p>\n

Patient Connect enables individuals to upload and verify medical records, match to clinical trials using AI, communicate with coordinators, and share data securely with providers. Already in use by thousands of cancer patients globally, the platform integrates key CMS features such as \u201ckill the clipboard\u201d<\/strong> (FHIR-based digital check-in), IAL2\/AAL2 identity verification<\/strong>, and Medicare connectivity<\/strong>.<\/p>\n

\u201cThis is infrastructure for health equity,\u201d said \u00c7a\u011fatay \u00c7ulcuo\u011flu<\/strong><\/a>, CTO and Co-Founder<\/strong>. \u201cWe\u2019ve engineered Patient Connect to comply with FHIR standards, Smart Health Cards, and seamless credentialing, removing fragmentation and putting data back into the hands of those it belongs to: the patient.\u201d<\/p>\n

The company\u2019s virtual assistant, DrArturoAI<\/strong>,<\/a> complements the app by offering conversational, context-aware AI support<\/strong>. Patients can receive educational guidance, symptom triage, care navigation, and trial opportunities; all transparently flagged when AI-generated and seamlessly integrated with provider care pathways.<\/p>\n

\u201cWith DrArturoAI, we\u2019ve built something that feels human, helpful, and honest,\u201d said Dr. <\/strong>Arturo Loaiza-Bonilla<\/strong><\/a> MD, Chief Medical Officer and Co-Founder<\/strong>. \u201cIt\u2019s the bridge between fragmented data and actionable care. Our prescreening hubs and AI-powered analytics create a mission-control capability that works 24\/7 to identify and match patients in full patient centricity. This is responsible AI in service of patients, and a model for how CMS-aligned health tech can serve every American.\u201d<\/p>\n

What Massive Bio Has Already Delivered<\/strong><\/p>\n\n\n\n\n\n\n\n
CMS Pillar<\/strong><\/td>\nMassive Bio Implementation<\/strong><\/td>\n<\/tr>\n
Kill the Clipboard<\/strong><\/td>\nDigital FHIR check-in, QR\/Smart Health Cards, visit summaries<\/td>\n<\/tr>\n
AI-Powered Assistant<\/strong><\/td>\nDrArturoAI & AskFionaAI: Safe, transparent, triage & support<\/td>\n<\/tr>\n
CMS Identity Compliance<\/strong><\/td>\nIAL2\/AAL2 credentials, Medicare notifications, HIPAA compliant<\/td>\n<\/tr>\n
Chronic Condition Support<\/strong><\/td>\nTrial eligibility tied to clinical record insights for cancer, obesity, prediabetes<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

A National Commitment to Patient-Centered Innovation<\/strong><\/p>\n

Massive Bio is actively collaborating with CMS and fellow early adopters to help operationalize the interoperability framework<\/strong>, participate in app store pilots for Medicare.gov, and expand patient access through aligned health systems and pharmacy networks.<\/p>\n

\u201cWe salute CMS for spearheading a future-ready ecosystem that prioritizes transparency, equity, and access,\u201d said Kurnaz. \u201cThis isn\u2019t just compliance, it\u2019s our calling.\u201d<\/p>\n

About Massive Bio<\/strong><\/p>\n

Massive Bio, co-founded by Selin Kurnaz<\/strong><\/a>,<\/strong> Arturo Loaiza-Bonilla<\/strong><\/a>, and \u00c7a\u011fatay \u00c7ulcuo\u011flu<\/strong><\/a>, transforms the pharmaceutical value chain with AI-driven solutions. As an AI-enabled real-world data company, it streamlines the patient journey, enhances access to advanced treatment options, and optimizes clinical trials. Massive Bio collaborates with pharmaceutical companies, research organizations, and healthcare institutions worldwide. A founding member of the CancerX public-private partnership and participant in the Cancer Moonshot White House initiative, the company has received recognition from the National Cancer Institute and operates across 17 countries with a global team of over 100 employees. For more information, visit www.massivebio.com<\/a>.<\/p>\n

Explore Patient Connect<\/strong> \u2192 massivebio.com\/patient-connect<\/a>
\nMeet DrArturoAI<\/strong> \u2192 drarturo.ai<\/a><\/p>\n

Media Contact:<\/strong>
\nMassive Bio
\nMert Turkkan,
\nMarketing Director
\nmturkkan@massivebio.com<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"Boca Raton, FL \u2013 July 31, 2025 \u2014 In direct support of the White House and CMS\u2019s bold initiative to \u201cMake Health Tech Great Again,\u201d Massive Bio, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem and reaffirmed its mission to modernize clinical trial access through secure, AI-powered...","protected":false},"author":11,"featured_media":36447,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-36442","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"\nMASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant<\/title>\n<meta name=\"description\" content=\"Boca Raton, FL \u2013 July 31, 2025 \u2014 In direct support of the White House and CMS\u2019s bold initiative to \u201cMake Health Tech Great Again,\u201d Massive Bio, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem and reaffirmed its mission to modernize clinical trial access through secure, AI-powered patient-facing technology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant %\" \/>\n<meta property=\"og:description\" content=\"Boca Raton, FL \u2013 July 31, 2025 \u2014 In direct support of the White House and CMS\u2019s bold initiative to \u201cMake Health Tech Great Again,\u201d Massive Bio, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem and reaffirmed its mission to modernize clinical trial access through secure, AI-powered patient-facing technology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-31T13:54:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-31T14:04:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/MB-CMS-PR-WebVisual.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"767\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant","description":"Boca Raton, FL \u2013 July 31, 2025 \u2014 In direct support of the White House and CMS\u2019s bold initiative to \u201cMake Health Tech Great Again,\u201d Massive Bio, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem and reaffirmed its mission to modernize clinical trial access through secure, AI-powered patient-facing technology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/","og_locale":"en_US","og_type":"article","og_title":"MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant %","og_description":"Boca Raton, FL \u2013 July 31, 2025 \u2014 In direct support of the White House and CMS\u2019s bold initiative to \u201cMake Health Tech Great Again,\u201d Massive Bio, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem and reaffirmed its mission to modernize clinical trial access through secure, AI-powered patient-facing technology.","og_url":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2025-07-31T13:54:30+00:00","article_modified_time":"2025-07-31T14:04:12+00:00","og_image":[{"width":1024,"height":767,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/MB-CMS-PR-WebVisual.webp","type":"image\/webp"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant","datePublished":"2025-07-31T13:54:30+00:00","dateModified":"2025-07-31T14:04:12+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/"},"wordCount":639,"commentCount":8,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/MB-CMS-PR-WebVisual.webp","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/","url":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/","name":"MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/MB-CMS-PR-WebVisual.webp","datePublished":"2025-07-31T13:54:30+00:00","dateModified":"2025-07-31T14:04:12+00:00","description":"Boca Raton, FL \u2013 July 31, 2025 \u2014 In direct support of the White House and CMS\u2019s bold initiative to \u201cMake Health Tech Great Again,\u201d Massive Bio, leader in AI-enabled oncology trial matching, announced its full alignment with the CMS Health Tech Ecosystem and reaffirmed its mission to modernize clinical trial access through secure, AI-powered patient-facing technology.","breadcrumb":{"@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/MB-CMS-PR-WebVisual.webp","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/07\/MB-CMS-PR-WebVisual.webp","width":1024,"height":767,"caption":"MB CMS PR WebVisual"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/massive-bio-delivers-on-cms-interoperability-vision-with-live-patient-connect-app-and-ai-trial-matching-assistant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"MASSIVE BIO Delivers on CMS Interoperability Vision with Live Patient Connect App and AI Trial Matching Assistant"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists & Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/36442","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=36442"}],"version-history":[{"count":2,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/36442\/revisions"}],"predecessor-version":[{"id":36446,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/36442\/revisions\/36446"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/36447"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=36442"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=36442"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=36442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}